Home » Healthcare » Venous Stents Market

Venous Stents Market By Application Leg, Chest, Abdomen, Others By Disease, Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, Others)-Growth, Future Prospects & Competitive Analysis, 2016 – 2030

Price: $4999

Published: | Report ID: 18135 | Report Format : PDF

Key Highlights of the Report

The global venous stents market is segmented by application, disease, and region. Leg venous stents are the most popular segment. Sales of venous stents are highest for chronic deep vein thrombosis treatment, with North America leading the market growth.

The global venous stents market has several drivers, including over the upcoming years; the Venous Stents Market is expected to be driven by increased investments made by major companies in developing flexible venous stents with high radial strength and rising healthcare spending. However, the high cost of venous stent procedures, the scarcity of experts with the necessary skills, and the potential for complications with venous stent placement. The high cost of venous stent procedures significantly constrains the market.

Nonetheless, the global venous stents market offers significant growth opportunities due to the world’s expanding senior population, as older individuals are more susceptible to heart-related issues.

Market Overview

The global venous stents market has witnessed steady growth in recent years and is expected to continue growing at a CAGR of 8.50% between 2023 and 2030. The market was valued at USD 0.87 Billion in 2022 and is expected to reach USD 1.54 Billion in 2030.

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

CTA Design Element 3

What Are the Main Drivers of The Global Venous Stents Market?

The global venous stents market is driven by several factors, including over the upcoming years; the Venous Stents Market is expected to be driven by increased investments made by major companies in developing flexible venous stents with high radial strength and rising healthcare spending.

What Are the Major Challenges Faced By The Global Venous Stents Market?

The global venous stent market also faces several challenges, including the high cost of venous stent procedures, the scarcity of experts with the necessary skills, and the potential for complications with venous stent placement. The high cost of venous stent procedures significantly constrains the market.

What Are the Growth Opportunities in The Global Venous Stents Market?

The global venous stents market offers significant growth opportunities, as older individuals are more susceptible to heart-related issues due to the world’s expanding senior population.

Executive Summary

Overview of the Global Venous Stents Market

The global venous stents Market held a valuation of USD 0.87 Billion in 2022, and it is anticipated to expand at a CAGR of 8.50% over the forecasted years. The market for venous stents is expanding because venous illnesses like chronic venous insufficiency, deep vein thrombosis, phlebitis, varicose and spider veins, and venous stenosis are becoming more common. The market is driven by the increasing frequency of venous problems among people, which are necessary for treating the disorders above and necessitating venous stents.

Market Definition

Venous stents are metal mesh tubes that are put into the veins to treat chronic symptoms of venous disorders. The way venous stents work is similar to how arterial stents work. They are available in a range of styles and dimensions. Stents are typically delivered to their target location utilizing a vascular catheter and in a compressed state. Some require the aid of an inflated balloon, while others may expand on their own. These stents widen against the constricted or blocked veins and keep them open. They serve as a scaffold for the vascular walls and are flexible devices employed in peripheral and central veins. Surgeons typically implanted Venous stents in larger, more central veins, such as those in the legs, belly, and chest.

Most stents are extremely challenging to remove if necessary and stay in place forever once implanted. Some stents can also be coated with drugs or have special coatings that gradually release them. Depending on the application, the market is divided into Leg, Chest, Abdomen, and Others. The market is classified into Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, and Others based on the disease.

Market Insights

  • The global demand for venous stents was valued at USD 0.87 Billion in 2022 and is expected to reach USD 1.54 Billion in 2030, growing at a CAGR of 8.50% between 2023 and 2030.
  • The leg is the leading segment by application and held over 43% share in terms of value in 2022.
  • The chronic deep vein thrombosis segment governs the demand for venous stents globally, holding a massive share of over 80% in 2022, and is expected to grow at a rapid CAGR.
  • North America is fueling the growth of the venous stents industry with the over one-third share in 2022, while Asia Pacific and Europe collectively account for just under 50% share in 2022. Europe held over 22% share in 2022.
  • The existence of major firms and their use of cutting-edge medical technologies to manufacture products are primarily responsible for the largest share.
  • In addition, a well-developed healthcare infrastructure and significant financial investments in the sector are major drivers of its significant market share.

Segmentation by Application

  • The leg is the leading segment by application and held over 43% share in terms of value in 2022.
  • The chest segment will likely exhibit the fastest CAGR during the forecast period.

Segmentation by Disease

  • The chronic deep vein thrombosis segment governs the demand for venous stents globally, holding a massive share of over 80% in 2022, and is also expected to grow at a rapid CAGR.

Segmentation by Region

  • Asia Pacific is fueling the growth of the venous stents industry with over one-third share in 2022.
  • North America and Europe collectively account for just under 50% share in 2022, with Europe holding over 22% share in the same year.
  • The rest of the World, including Latin America, The Middle East, and Africa, contributes the remainder to the demand for venous stents.

The increasing demand for venous stents can be attributed to the existence of major firms, and their use of cutting-edge medical technologies to manufacture products is primarily responsible for the largest share. However, the market is restrained by a lack of awareness of venous stents and the high cost of stenting.

The United States is one of North America’s largest markets for venous stents, with a significant market share. Due to the presence of major businesses and their use of cutting-edge medical technology in product development, the largest share is mostly attributable to these factors. In addition, a well-developed healthcare infrastructure and substantial financial investments in the sector are the main factors influencing its considerable market share. Additionally, several factors are anticipated to boost market growth, including advantageous government efforts and increased research collaboration numbers.

China is also a major market for venous stents in the Asia Pacific region, with a significant market share. Lower extremity DVT frequency and detection rates are rising, and stenting and other minimally invasive procedures have been linked to better clinical results. Like Western nations, the APAC area is seeing increased use of stents. The absence of venous stents and the lack of approval of those available can be blamed for the low stenting rate in the APAC region.

Venous Stents Market

Cardiovascular Disorders are Becoming More Common

Whether or not vascular stenting is used, angioplasty is a minimally invasive technique. Angioplasty is used to widen or clear an artery or vein to flow more blood. It usually occurs in an interventional radiology room instead of an operating room.

During percutaneous transluminal angioplasty, a prospective minimally invasive treatment for constricting arteries is carried out. In addition, leading manufacturers are working to deploy premium drug-eluting venous stents to produce exceptional healthcare results. Drug-eluting stents (DES) have been developed to solve the primary shortcomings of coated or bare metal stents.

Growing Uses of Venous Stents in Healthcare to Fuel Market Growth for Venous Stents in Healthcare

Venous diseases refer to illnesses that harm the veins. Several common venous illnesses include thrombophlebitis, deep vein thrombosis, venous stasis, venous ulcers, arteriovenous fistulas, and others. In the US, about 15% of people have varicose veins, according to Johns Hopkins University. According to the Centers for Disease Control and Prevention, deep vein thrombosis (DVT) affects over 900,000 (1–2 per 1,000) persons year in the United States. Furthermore, it was stated that 33% of DVT patients will experience a recurrence of their condition within ten years. In addition, the condition known as thrombophilia is one in which a propensity to clot formation exists.

Genetic thrombophilia, which originates from a deficit in a hereditary factor such as antithrombin or protein C, can cause the tendency to produce clots. According to the Centres for Disease Control and Prevention, thrombophilia is inherited by 5-8% of US citizens.

The Risk of Complications, The High Expense of Venous Stent Procedures, and The Shortage of Specialists With the Necessary Skills

The market for venous stents is constrained by factors such as the high cost of treatments, the absence of qualified specialists, and the possibility of complications from venous stent implantation. An important factor limiting the market growth for venous stents is the high cost of these treatments, which prevents poorer nations from adopting them. The growth of the venous stent market has additional difficulties due to the limited accessibility of these operations in some areas due to a lack of qualified experts.

Rigid Standards for Product Approval

The production of stents is anticipated to be slowed by the government’s strict norms and policies for medical device approvals. Several venous procedure devices have been recalled from the market due to recent evidence of unanticipated unfavorable patient outcomes. For instance, Vascular Solutions Inc. had to recall almost 7,000 of its venture catheters in 2017 because the catheter tip had excess material that could have broken off during operations and resulted in blood clots. Leading medical device makers carefully examine and test each product in the lab before releasing it, preventing any anomaly from emerging during the trials. This limits the long-term development potential of venous stents by shortening the effective shelf life of crucial surgical equipment.

The World’s Ageing Population, as Older People are More Susceptible to Heart-Related Issues.

Because older people are more susceptible to heart-related issues, there are more chronic cardiovascular illness cases worldwide due to the world’s aging population. According to the WHO, around 17.9 million deaths worldwide occur yearly due to cardiovascular diseases (CVDs). As a result, the demand for cardiovascular surgery rises in tandem with the prevalence of CVD among people, spurring market growth. Additionally, obesity is a significant global risk factor for several heart conditions. Obesity can cause excessive or inappropriate fat deposition in the artery wall, resulting in coronary heart disease and other health problems. As a result, the rising obesity rate may necessitate more venous procedures, which would indirectly support market expansion.

Competitive Landscape

Key Players

The global venous stents market is highly competitive, with the presence of several key players. Some of the major players in the market and their market share are as follows:

  • Boston Scientific Corporation
  • Becton, Dickinson and Company
  • Gore Medical
  • Cook Medical
  • Optimed Medizinische Instrumente GmBH
  •  Medtronic Plc
  • Medica Germany GMBH & Co. KG
  • Cordis Inc.
  • MicroPort Scientific Corporation

These companies focus on product innovation, expanding their distribution channels, and mergers and acquisitions to stay ahead in the market. The major players in the global venous stents market constantly strive to stay ahead by introducing new products and innovations.

The US Food and Drug Administration (FDA) approved the Medtronic abbre venous self-expanding stent system for usage in October 2020. This device is recommended for patients with symptomatic deep venous obstruction, also known as iliofemoral venous outflow obstruction.

In March 2022, the FDA approved the “S.M.A.R.T. RADIANZ Vascular Stent System” from Cordis, a self-expanding stent designed especially for radial peripheral surgeries. The superficial femoral (SFA) and iliac arteries can be stented more successfully and accurately thanks to the S.M.A.R.T. RADIANZ Vascular Stent System.

The Pulsar-18 T3 peripheral self-expanding stent system from BIOTRONIK was approved by the U.S. Food and Drug Administration (FDA) in July 2021 for a better implantation method during endovascular procedures.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Summary of Key Findings

  • Investments made by major companies in developing flexible venous stents with high radial strength and rising healthcare spending are driving market growth.
  • Market segmented by application, disease, and region.
  • Legs venous stents are the most popular segment.
  • Chronic deep vein thrombosis most commonly occurs in the disease.
  • North America is leading market growth; the market is highly competitive with key players including Boston Scientific Corporation, Becton, Dickinson and Company, Gore Medical, Cook Medical, Optimed Medizinische Instrumente GmBH, Medtronic Plc, Medica Germany GMBH & Co. KG, Cordis Inc., and MicroPort Scientific Corporation.

Future Outlook

  • Positive outlook for the global venous stents market with significant growth potential in the North American region
  • As older individuals are more susceptible to heart-related issues due to the world’s expanding senior population driving growth
  • Challenges to a shortage of qualified experts restrict the availability of these operations in some areas.
  • Key players to focus on product innovation, expanding market reach and maintaining competitive pricing to stay ahead.

Segmentation

  • By Application
    • Leg
    • Chest
    • Abdomen
    • Others
  • By Disease
    • Chronic Deep Vein Thrombosis
    • Post Thrombotic Syndrome
    • Others
  • By Region
  • North America
    • The US.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • The U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • South-east Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of the Middle East and Africa

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Data Modelling
1.3.2.1. Company Share Analysis Model
1.3.2.2. Revenue Based Modelling
1.3.3. Phase III – Primary Research
1.3.4. Research Limitations
1.3.5. Assumptions
1.4. Market Introduction
1.5. Market Research Scope

2. Executive Summary
2.1. Market Snapshot: Global Venous Stents Market
2.2. Global Venous Stents Market, By Application
2.3. Global Venous Stents Market, By Disease
2.4. Global Venous Stents Market, By Region

3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global Venous Stents Market Value, 2017-2030, (US$ Bn)
3.1.2. Y-o-Y Growth Trend Analysis
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.1.1. Driver 1
3.2.1.2. Driver 2
3.2.1.3. Driver 3
3.2.2. Market Restraints
3.2.2.1. Restraint 1
3.2.2.2. Restraint 2
3.2.3. Market Opportunities
3.2.3.1. Opportunity 1
3.2.3.2. Opportunity 2
3.2.4. Major Industry Challenges
3.2.4.1. Challenge 1
3.2.4.2. Challenge 2
3.3. Growth and Development Patterns
3.4. Investment Feasibility Analysis
3.5. Market Opportunity Analysis
3.5.1. Application
3.5.2. Disease
3.5.3. Geography

4. Premium Insights
4.1. STAR (Situation, Task, Action, Results) Analysis
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers/Consumers
4.2.3. Bargaining Power of Suppliers
4.2.4. Threat of Substitute Applications
4.2.5. Intensity of Competitive Rivalry
4.3. Key Market Trends
4.3.1. Demand Side Trends
4.3.2. Supply Side Trends
4.4. Value Chain Analysis
4.5. Application Analysis
4.6. Analysis and Recommendations
4.7. Marketing Strategy Analysis
4.7.1. Direct Marketing
4.7.2. Indirect Marketing
4.7.3. Marketing Channel Development Trend

5. Market Positioning of Key Players, 2022
5.1. Company market share of key players, 2022
5.2. Competitive Benchmarking
5.3. Market Positioning of Key Vendors
5.4. Geographical Presence Analysis
5.5. Major Strategies Adopted by Key Players
5.5.1. Key Strategies Analysis
5.5.2. Mergers and Acquisitions
5.5.3. Partnerships
5.5.4. Product Launch
5.5.5. Geographical Expansion
5.5.6. Others

6. Economic Impact Analysis
6.1. Recession Impact
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Latin America
6.1.5. Middle East and Africa
6.2. Ukraine-Russia War Impact
6.2.1. North America
6.2.2. Europe
6.2.3. Asia Pacific
6.2.4. Latin America
6.2.5. Middle East and Africa
6.3. COVID-19 Impact Analysis
6.3.1. North America
6.3.2. Europe
6.3.3. Asia Pacific
6.3.4. Latin America
6.3.5. Middle East and Africa

7. Global Venous Stents Market, By Application
7.1. Global Venous Stents Market Overview, by Application
7.1.1. Global Venous Stents Market Revenue Share, By Application, 2022 Vs 2030 (in %)
7.2. Leg
7.2.1. Global Venous Stents Market, By Region, 2017-2030 (US$ Bn)
7.3. Chest
7.3.1. Global Venous Stents Market, By Region, 2017-2030 (US$ Bn)
7.4. Abdomen
7.4.1. Global Venous Stents Market, By Region, 2017-2030 (US$ Bn)
7.5. Others
7.5.1. Global Venous Stents Market, By Region, 2017-2030 (US$ Bn)

8. Global Venous Stents Market, By Disease
8.1. Global Venous Stents Market Overview, by Disease
8.1.1. Global Venous Stents Market, By Disease, 2022 vs 2030 (in %)
8.2. Chronic Deep Vein Thrombosis
8.2.1. Global Venous Stents Market, By Region, 2017-2030 (US$ Bn)
8.3. Post Thrombotic Syndrome
8.3.1. Global Venous Stents Market, By Region, 2017-2030 (US$ Bn)
8.4. Others
8.4.1. Global Venous Stents Market, By Region, 2017-2030 (US$ Bn)

9. Global Venous Stents Market, By Region
9.1. Global Venous Stents Market Overview, by Region
9.1.1. Global Venous Stents Market, By Region, 2022 vs 2030 (in%)
9.2. Application
9.2.1. Global Venous Stents Market, By Application, 2017-2030 (US$ Bn)
9.3. Disease
9.3.1. Global Venous Stents Market, By Disease, 2017-2030 (US$ Bn)

10. North America Venous Stents Market Analysis
10.1. North America Venous Stents Market, by Application, 2017-2030(US$ Bn)
10.1.1. Overview
10.1.2. SRC Analysis
10.2. North America Venous Stents Market, by Disease, 2017-2030(US$ Bn)
10.2.1. Overview
10.2.2. SRC Analysis
10.3. North America Venous Stents Market, by Country, 2017-2030 (US$ Bn)
10.3.1. North America Venous Stents Market, by Country, 2022 Vs 2030 (in%)
10.3.2. U.S.
10.3.2.1. U.S. Venous Stents Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.3.2.2. U.S. Venous Stents, By Application, 2017-2030 (US$ Bn)
10.3.2.3. U.S. Venous Stents, By Disease, 2017-2030 (US$ Bn)
10.3.3. Canada
10.3.3.1. Canada Venous Stents Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.3.3.2. Canada Venous Stents, By Application, 2017-2030 (US$ Bn)
10.3.3.3. Canada Venous Stents, By Disease, 2017-2030 (US$ Bn)
10.3.4. Mexico
10.3.4.1. Mexico Venous Stents Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.3.4.2. Mexico Venous Stents, By Application, 2017-2030 (US$ Bn)
10.3.4.3. Mexico Venous Stents, By Disease, 2017-2030 (US$ Bn)

11. Europe Venous Stents Market Analysis
11.1. Europe Venous Stents Market, by Application, 2017-2030(US$ Bn)
11.1.1. Overview
11.1.2. SRC Analysis
11.2. Europe Venous Stents Market, by Disease, 2017-2030(US$ Bn)
11.2.1. Overview
11.2.2. SRC Analysis
11.3. Europe Venous Stents Market, by Country, 2017-2030 (US$ Bn)
11.3.1. Europe Venous Stents Market, by Country, 2022 Vs 2030 (in%)
11.3.2. Germany
11.3.2.1. Germany Venous Stents Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.3.2.2. Germany Venous Stents, By Application, 2017-2030 (US$ Bn)
11.3.2.3. Germany Venous Stents, By Disease, 2017-2030 (US$ Bn)
11.3.3. France
11.3.3.1. France Venous Stents Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.3.3.2. France Venous Stents, By Application, 2017-2030 (US$ Bn)
11.3.3.3. France Venous Stents, By Disease, 2017-2030 (US$ Bn)
11.3.4. UK
11.3.4.1. UK Venous Stents Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.3.4.2. UK Venous Stents, By Application, 2017-2030 (US$ Bn)
11.3.4.3. UK Venous Stents, By Disease, 2017-2030 (US$ Bn)
11.3.5. Italy
11.3.5.1. Italy Venous Stents Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.3.5.2. Italy Venous Stents, By Application, 2017-2030 (US$ Bn)
11.3.5.3. Italy Venous Stents, By Disease, 2017-2030 (US$ Bn)
11.3.6. Spain
11.3.6.1. Spain Venous Stents Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.3.6.2. Spain Venous Stents, By Application, 2017-2030 (US$ Bn)
11.3.6.3. Spain Venous Stents, By Disease, 2017-2030 (US$ Bn)
11.3.7. Rest of Europe
11.3.7.1. Rest of Europe Venous Stents Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.3.7.2. Rest of Europe Venous Stents, By Application, 2017-2030 (US$ Bn)
11.3.7.3. Rest of Europe Venous Stents, By Disease, 2017-2030 (US$ Bn)

12. Asia Pacific Venous Stents Market Analysis
12.1. Asia Pacific Venous Stents Market, by Application, 2017-2030(US$ Bn)
12.1.1. Overview
12.1.2. SRC Analysis
12.2. Asia Pacific Venous Stents Market, by Disease, 2017-2030(US$ Bn)
12.2.1. Overview
12.2.2. SRC Analysis
12.3. Asia Pacific Venous Stents Market, by Country, 2017-2030 (US$ Bn)
12.3.1. Asia Pacific Venous Stents Market, by Country, 2022 Vs 2030 (in%)
12.3.2. China
12.3.2.1. China Venous Stents Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.3.2.2. China Venous Stents, By Application, 2017-2030 (US$ Bn)
12.3.2.3. China Venous Stents, By Disease, 2017-2030 (US$ Bn)
12.3.3. Japan
12.3.3.1. Japan Venous Stents Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.3.3.2. Japan Venous Stents, By Application, 2017-2030 (US$ Bn)
12.3.3.3. Japan Venous Stents, By Disease, 2017-2030 (US$ Bn)
12.3.4. India
12.3.4.1. India Venous Stents Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.3.4.2. India Venous Stents, By Application, 2017-2030 (US$ Bn)
12.3.4.3. India Venous Stents, By Disease, 2017-2030 (US$ Bn)
12.3.5. South Korea
12.3.5.1. South Korea Venous Stents Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.3.5.2. South Korea Venous Stents, By Application, 2017-2030 (US$ Bn)
12.3.5.3. South Korea Venous Stents, By Disease, 2017-2030 (US$ Bn)
12.3.6. South-East Asia
12.3.6.1. South-East Asia Venous Stents Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.3.6.2. South-East Asia Venous Stents, By Application, 2017-2030 (US$ Bn)
12.3.6.3. South-East Asia Venous Stents, By Disease, 2017-2030 (US$ Bn)
12.3.7. Rest of Asia Pacific
12.3.7.1. Rest of Asia Pacific Venous Stents Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.3.7.2. Rest of Asia Pacific Venous Stents, By Application, 2017-2030 (US$ Bn)
12.3.7.3. Rest of Asia Pacific Venous Stents, By Disease, 2017-2030 (US$ Bn)

13. Latin America Venous Stents Market Analysis
13.1. Latin America Venous Stents Market, by Application, 2017-2030(US$ Bn)
13.1.1. Overview
13.1.2. SRC Analysis
13.2. Latin America Venous Stents Market, by Disease, 2017-2030(US$ Bn)
13.2.1. Overview
13.2.2. SRC Analysis
13.3. Latin America Venous Stents Market, by Country, 2017-2030 (US$ Bn)
13.3.1. Latin America Venous Stents Market, by Country, 2022 Vs 2030 (in%)
13.3.2. Brazil
13.3.2.1. Brazil Venous Stents Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.3.2.2. Brazil Venous Stents, By Application, 2017-2030 (US$ Bn)
13.3.2.3. Brazil Venous Stents, By Disease, 2017-2030 (US$ Bn)
13.3.3. Argentina
13.3.3.1. Argentina Venous Stents Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.3.3.2. Argentina Venous Stents, By Application, 2017-2030 (US$ Bn)
13.3.3.3. Argentina Venous Stents, By Disease, 2017-2030 (US$ Bn)
13.3.4. Rest of Latin America
13.3.4.1. Rest of Latin America Venous Stents Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.3.4.2. Rest of Latin America Venous Stents, By Application, 2017-2030 (US$ Bn)
13.3.4.3. Rest of Latin America Venous Stents, By Disease, 2017-2030 (US$ Bn)

14. Middle East and Africa Venous Stents Market Analysis
14.1. Middle East and Africa Venous Stents Market, by Application, 2017-2030(US$ Bn)
14.1.1. Overview
14.1.2. SRC Analysis
14.2. Middle East and Africa Venous Stents Market, by Disease, 2017-2030(US$ Bn)
14.2.1. Overview
14.2.2. SRC Analysis
14.3. Middle East and Africa Venous Stents Market, by Country, 2017-2030 (US$ Bn)
14.3.1. Middle East and Africa Venous Stents Market, by Country, 2022 Vs 2030 (in%)
14.3.2. GCC Countries
14.3.2.1. GCC Countries Venous Stents Market Estimates and Forecast, 2017-2030 (US$ Bn)
14.3.2.2. GCC Countries Venous Stents, By Application, 2017-2030 (US$ Bn)
14.3.2.3. GCC Countries Venous Stents, By Disease, 2017-2030 (US$ Bn)
14.3.3. South Africa
14.3.3.1. South Africa Venous Stents Market Estimates and Forecast, 2017-2030 (US$ Bn)
14.3.3.2. South Africa Venous Stents, By Application, 2017-2030 (US$ Bn)
14.3.3.3. South Africa Venous Stents, By Disease, 2017-2030 (US$ Bn)
14.3.4. Rest of Middle East and Africa
14.3.4.1. Rest of Middle East and Africa Venous Stents Market Estimates and Forecast, 2017-2030 (US$ Bn)
14.3.4.2. Rest of Middle East and Africa Venous Stents, By Application, 2017-2030 (US$ Bn)
14.3.4.3. Rest of Middle East and Africa Venous Stents, By Disease, 2017-2030 (US$ Bn)

15. Company Profiles
15.1. Boston Scientific Corporation
15.1.1. Company Overview
15.1.2. Products/Services Portfolio
15.1.3. Geographical Presence
15.1.4. Financial Summary
15.1.4.1. Market Revenue and Net Profit (2019-2022)
15.1.4.2. Business Segment Revenue Analysis
15.1.4.3. Geographical Revenue Analysis
15.2. Becton, Dickinson and Company
15.3. Gore Medical
15.4. Cook Medical
15.5. Optimed Medizinische Instrumente GmBH
15.6. Medtronic Plc
15.7. Medica Germany GMBH & Co. KG
15.8. Cordis Inc.
15.9. MicroPort Scientific Corporation

List of Figures
FIG. 1 Global Venous Stents Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global Venous Stents Market Segmentation
FIG. 4 Global Venous Stents Market, by Application, 2022 (US$ Bn)
FIG. 5 Global Venous Stents Market, by Disease, 2022 (US$ Bn)
FIG. 6 Global Venous Stents Market, by Geography, 2022 (US$ Bn)
FIG. 7 Attractive Investment Proposition, by Application, 2022
FIG. 8 Attractive Investment Proposition, by Disease, 2022
FIG. 9 Attractive Investment Proposition, by Geography, 2022
FIG. 10 Global Market Share Analysis of Key Venous Stents Market Manufacturers, 2022
FIG. 11 Global Market Positioning of Key Venous Stents Market Manufacturers, 2022
FIG. 12 Global Venous Stents Market Value Contribution, By Application, 2022 & 2030 (Value %)
FIG. 13 Global Venous Stents Market, by Leg, Value, 2017-2030 (US$ Bn)
FIG. 14 Global Venous Stents Market, by Chest, Value, 2017-2030 (US$ Bn)
FIG. 15 Global Venous Stents Market, by Abdomen, Value, 2017-2030 (US$ Bn)
FIG. 16 Global Venous Stents Market, by Others, Value, 2017-2030 (US$ Bn)
FIG. 17 Global Venous Stents Market Value Contribution, By Disease, 2022 & 2030 (Value %)
FIG. 18 Global Venous Stents Market, by Chronic Deep Vein Thrombosis, Value, 2017-2030 (US$ Bn)
FIG. 19 Global Venous Stents Market, by Post Thrombotic Syndrome, 2017-2030 (US$ Bn)
FIG. 20 Global Venous Stents Market, by Others, 2017-2030 (US$ Bn)
FIG. 21 North America Venous Stents Market, 2017-2030 (US$ Bn)
FIG. 22 U.S. Venous Stents Market, 2017-2030 (US$ Bn)
FIG. 23 Canada Venous Stents Market, 2017-2030 (US$ Bn)
FIG. 24 Europe Venous Stents Market, 2017-2030 (US$ Bn)
FIG. 25 Germany Venous Stents Market, 2017-2030 (US$ Bn)
FIG. 26 France Venous Stents Market, 2017-2030 (US$ Bn)
FIG. 27 U.K. Venous Stents Market, 2017-2030 (US$ Bn)
FIG. 28 Italy Venous Stents Market, 2017-2030 (US$ Bn)
FIG. 29 Spain Venous Stents Market, 2017-2030 (US$ Bn)
FIG. 30 Rest of Europe Venous Stents Market, 2017-2030 (US$ Bn)
FIG. 31 Asia Pacific Venous Stents Market, 2017-2030 (US$ Bn)
FIG. 32 China Venous Stents Market, 2017-2030 (US$ Bn)
FIG. 33 Japan Venous Stents Market, 2017-2030 (US$ Bn)
FIG. 34 India Venous Stents Market, 2017-2030 (US$ Bn)
FIG. 35 South Korea Venous Stents Market, 2017-2030 (US$ Bn)
FIG. 36 South-East Asia Venous Stents Market, 2017-2030 (US$ Bn)
FIG. 37 Rest of Asia Pacific Venous Stents Market, 2017-2030 (US$ Bn)
FIG. 38 Latin America Venous Stents Market, 2017-2030 (US$ Bn)
FIG. 39 Brazil Venous Stents Market, 2017-2030 (US$ Bn)
FIG. 40 Mexico Venous Stents Market, 2017-2030 (US$ Bn)
FIG. 41 Rest of Latin America Venous Stents Market, 2017-2030 (US$ Bn)
FIG. 42 Middle East & Africa Venous Stents Market, 2017-2030 (US$ Bn)
FIG. 43 GCC Countries Venous Stents Market, 2017-2030 (US$ Bn)
FIG. 44 South Africa Venous Stents Market, 2017-2030 (US$ Bn)
FIG. 45 Rest of Middle East and Africa Venous Stents Market, 2017-2030 (US$ Bn)

List of Tables
TABLE 1 Market Snapshot: Global Venous Stents Market
TABLE 2 Global Venous Stents Market: Market Drivers Impact Analysis
TABLE 3 Global Venous Stents Market: Market Restraints Impact Analysis
TABLE 4 Global Venous Stents Market, by Competitive Benchmarking, 2022
TABLE 5 Global Venous Stents Market, by Geographical Presence Analysis, 2022
TABLE 6 Global Venous Stents Market, by Key Strategies Analysis, 2022
TABLE 7 Global Venous Stents Market, by Leg, By Region, 2017-2022 (US$ Bn)
TABLE 8 Global Venous Stents Market, by Leg, By Region, 2023-2030 (US$ Bn)
TABLE 9 Global Venous Stents Market, by Chest, By Region, 2017-2022 (US$ Bn)
TABLE 10 Global Venous Stents Market, by Chest, By Region, 2023-2030 (US$ Bn)
TABLE 11 Global Venous Stents Market, by Abdomen, By Region, 2017-2022 (US$ Bn)
TABLE 12 Global Venous Stents Market, by Abdomen, By Region, 2023-2030 (US$ Bn)
TABLE 13 Global Venous Stents Market, by Others, By Region, 2017-2022 (US$ Bn)
TABLE 14 Global Venous Stents Market, by Others, By Region, 2023-2030 (US$ Bn)
TABLE 15 Global Venous Stents Market, by Chronic Deep Vein Thrombosis, By Region, 2017-2022 (US$ Bn)
TABLE 16 Global Venous Stents Market, by Chronic Deep Vein Thrombosis, By Region, 2023-2030 (US$ Bn)
TABLE 17 Global Venous Stents Market, by Post Thrombotic Syndrome, By Region, 2017-2022 (US$ Bn)
TABLE 18 Global Venous Stents Market, by Post Thrombotic Syndrome, By Region, 2023-2030 (US$ Bn)
TABLE 19 Global Venous Stents Market, by Others, By Region, 2017-2022 (US$ Bn)
TABLE 20 Global Venous Stents Market, by Others, By Region, 2023-2030 (US$ Bn)
TABLE 21 Global Venous Stents Market, by Application, 2017-2022 (US$ Bn)
TABLE 22 Global Venous Stents Market, by Application, 2023-2030 (US$ Bn)
TABLE 23 Global Venous Stents Market, by Disease, 2017-2022 (US$ Bn)
TABLE 24 Global Venous Stents Market, by Disease, 2023-2030 (US$ Bn)
TABLE 25 Global Venous Stents Market, by Region, 2017-2022 (US$ Bn)
TABLE 26 Global Venous Stents Market, by Region, 2023-2030 (US$ Bn)
TABLE 27 North America Venous Stents Market, by Application, 2017-2022 (US$ Bn)
TABLE 28 North America Venous Stents Market, by Application, 2023-2030 (US$ Bn)
TABLE 29 North America Venous Stents Market, by Disease, 2017-2022 (US$ Bn)
TABLE 30 North America Venous Stents Market, by Disease, 2023-2030 (US$ Bn)
TABLE 31 North America Venous Stents Market, by Country, 2017-2022 (US$ Bn)
TABLE 32 North America Venous Stents Market, by Country, 2023-2030 (US$ Bn)
TABLE 33 United States Venous Stents Market, by Application, 2017-2022 (US$ Bn)
TABLE 34 United States Venous Stents Market, by Application, 2023-2030 (US$ Bn)
TABLE 35 United States Venous Stents Market, by Disease, 2017-2022 (US$ Bn)
TABLE 36 United States Venous Stents Market, by Disease, 2023-2030 (US$ Bn)
TABLE 37 Canada Venous Stents Market, by Application, 2017-2022 (US$ Bn)
TABLE 38 Canada Venous Stents Market, by Application, 2023-2030 (US$ Bn)
TABLE 39 Canada Venous Stents Market, by Disease, 2017-2022 (US$ Bn)
TABLE 40 Canada Venous Stents Market, by Disease, 2023-2030 (US$ Bn)
TABLE 41 Mexico Venous Stents Market, by Application, 2017-2022 (US$ Bn)
TABLE 42 Mexico Venous Stents Market, by Application, 2023-2030 (US$ Bn)
TABLE 43 Mexico Venous Stents Market, by Disease, 2017-2022 (US$ Bn)
TABLE 44 Mexico Venous Stents Market, by Disease, 2023-2030 (US$ Bn)
TABLE 45 Europe Venous Stents Market, by Application, 2017-2022 (US$ Bn)
TABLE 46 Europe Venous Stents Market, by Application, 2023-2030 (US$ Bn)
TABLE 47 Europe Venous Stents Market, by Disease, 2017-2022 (US$ Bn)
TABLE 48 Europe Venous Stents Market, by Disease, 2023-2030 (US$ Bn)
TABLE 49 Europe Venous Stents Market, by Country, 2017-2022 (US$ Bn)
TABLE 50 Europe Venous Stents Market, by Country, 2023-2030 (US$ Bn)
TABLE 51 Germany Venous Stents Market, by Application, 2017-2022 (US$ Bn)
TABLE 52 Germany Venous Stents Market, by Application, 2023-2030 (US$ Bn)
TABLE 53 Germany Venous Stents Market, by Disease, 2017-2022 (US$ Bn)
TABLE 54 Germany Venous Stents Market, by Disease, 2023-2030 (US$ Bn)
TABLE 55 France Venous Stents Market, by Application, 2017-2022 (US$ Bn)
TABLE 56 France Venous Stents Market, by Application, 2023-2030 (US$ Bn)
TABLE 57 France Venous Stents Market, by Disease, 2017-2022 (US$ Bn)
TABLE 58 France Venous Stents Market, by Disease, 2023-2030 (US$ Bn)
TABLE 59 United Kingdom Venous Stents Market, by Application, 2017-2022 (US$ Bn)
TABLE 60 United Kingdom Venous Stents Market, by Application, 2023-2030 (US$ Bn)
TABLE 61 United Kingdom Venous Stents Market, by Disease, 2017-2022 (US$ Bn)
TABLE 62 United Kingdom Venous Stents Market, by Disease, 2023-2030 (US$ Bn)
TABLE 63 Italy Venous Stents Market, by Application, 2017-2022 (US$ Bn)
TABLE 64 Italy Venous Stents Market, by Application, 2023-2030 (US$ Bn)
TABLE 65 Italy Venous Stents Market, by Disease, 2017-2022 (US$ Bn)
TABLE 66 Italy Venous Stents Market, by Disease, 2023-2030 (US$ Bn)
TABLE 67 Spain Venous Stents Market, by Application, 2017-2022 (US$ Bn)
TABLE 68 Spain Venous Stents Market, by Application, 2023-2030 (US$ Bn)
TABLE 69 Spain Venous Stents Market, by Disease, 2017-2022 (US$ Bn)
TABLE 70 Spain Venous Stents Market, by Disease, 2023-2030 (US$ Bn)
TABLE 71 Rest of Europe Venous Stents Market, by Application, 2017-2022 (US$ Bn)
TABLE 72 Rest of Europe Venous Stents Market, by Application, 2023-2030 (US$ Bn)
TABLE 73 Rest of Europe Venous Stents Market, by Disease, 2017-2022 (US$ Bn)
TABLE 74 Rest of Europe Venous Stents Market, by Disease, 2023-2030 (US$ Bn)
TABLE 75 Asia Pacific Venous Stents Market, by Application, 2017-2022 (US$ Bn)
TABLE 76 Asia Pacific Venous Stents Market, by Application, 2023-2030 (US$ Bn)
TABLE 77 Asia Pacific Venous Stents Market, by Disease, 2017-2022 (US$ Bn)
TABLE 78 Asia Pacific Venous Stents Market, by Disease, 2023-2030 (US$ Bn)
TABLE 79 China Venous Stents Market, by Application, 2017-2022 (US$ Bn)
TABLE 80 China Venous Stents Market, by Application, 2023-2030 (US$ Bn)
TABLE 81 China Venous Stents Market, by Disease, 2017-2022 (US$ Bn)
TABLE 82 China Venous Stents Market, by Disease, 2023-2030 (US$ Bn)
TABLE 83 Japan Venous Stents Market, by Application, 2017-2022 (US$ Bn)
TABLE 84 Japan Venous Stents Market, by Application, 2023-2030 (US$ Bn)
TABLE 85 Japan Venous Stents Market, by Disease, 2017-2022 (US$ Bn)
TABLE 86 Japan Venous Stents Market, by Disease, 2023-2030 (US$ Bn)
TABLE 87 India Venous Stents Market, by Application, 2017-2022 (US$ Bn)
TABLE 88 India Venous Stents Market, by Application, 2023-2030 (US$ Bn)
TABLE 89 India Venous Stents Market, by Disease, 2017-2022 (US$ Bn)
TABLE 90 India Venous Stents Market, by Disease, 2023-2030 (US$ Bn)
TABLE 91 South Korea Venous Stents Market, by Application, 2017-2022 (US$ Bn)
TABLE 92 South Korea Venous Stents Market, by Application, 2023-2030 (US$ Bn)
TABLE 93 South Korea Venous Stents Market, by Disease, 2017-2022 (US$ Bn)
TABLE 94 South Korea Venous Stents Market, by Disease, 2023-2030 (US$ Bn)
TABLE 95 South-East Asia Venous Stents Market, by Application, 2017-2022 (US$ Bn)
TABLE 96 South-East Asia Venous Stents Market, by Application, 2023-2030 (US$ Bn)
TABLE 97 South-East Asia Venous Stents Market, by Disease, 2017-2022 (US$ Bn)
TABLE 98 South-East Asia Venous Stents Market, by Disease, 2023-2030 (US$ Bn)
TABLE 99 Rest of Asia Pacific Venous Stents Market, by Application, 2017-2022 (US$ Bn)
TABLE 100 Rest of Asia Pacific Venous Stents Market, by Application, 2023-2030 (US$ Bn)
TABLE 101 Rest of Asia Pacific Venous Stents Market, by Disease, 2017-2022 (US$ Bn)
TABLE 102 Rest of Asia Pacific Venous Stents Market, by Disease, 2023-2030 (US$ Bn)
TABLE 103 Latin America Venous Stents Market, by Application, 2017-2022 (US$ Bn)
TABLE 104 Latin America Venous Stents Market, by Application, 2023-2030 (US$ Bn)
TABLE 105 Latin America Venous Stents Market, by Disease, 2017-2022 (US$ Bn)
TABLE 106 Latin America Venous Stents Market, by Disease, 2023-2030 (US$ Bn)
TABLE 107 Brazil Venous Stents Market, by Application, 2017-2022 (US$ Bn)
TABLE 108 Brazil Venous Stents Market, by Application, 2023-2030 (US$ Bn)
TABLE 109 Brazil Venous Stents Market, by Disease, 2017-2022 (US$ Bn)
TABLE 110 Brazil Venous Stents Market, by Disease, 2023-2030 (US$ Bn)
TABLE 111 Argentina Venous Stents Market, by Application, 2017-2022 (US$ Bn)
TABLE 112 Argentina Venous Stents Market, by Application, 2023-2030 (US$ Bn)
TABLE 113 Argentina Venous Stents Market, by Disease, 2017-2022 (US$ Bn)
TABLE 114 Argentina Venous Stents Market, by Disease, 2023-2030 (US$ Bn)
TABLE 115 Rest of Latin America Venous Stents Market, by Application, 2017-2022 (US$ Bn)
TABLE 116 Rest of Latin America Venous Stents Market, by Application, 2023-2030 (US$ Bn)
TABLE 117 Rest of Latin America Venous Stents Market, by Disease, 2017-2022 (US$ Bn)
TABLE 118 Rest of Latin America Venous Stents Market, by Disease, 2023-2030 (US$ Bn)
TABLE 119 Middle East and Africa Venous Stents Market, by Application, 2017-2022 (US$ Bn)
TABLE 120 Middle East and Africa Venous Stents Market, by Application, 2023-2030 (US$ Bn)
TABLE 121 Middle East and Africa Venous Stents Market, by Disease, 2017-2022 (US$ Bn)
TABLE 122 Middle East and Africa Venous Stents Market, by Disease, 2023-2030 (US$ Bn)
TABLE 123 GCC Countries Venous Stents Market, by Application, 2017-2022 (US$ Bn)
TABLE 124 GCC Countries Venous Stents Market, by Application, 2023-2030 (US$ Bn)
TABLE 125 GCC Countries Venous Stents Market, by Disease, 2017-2022 (US$ Bn)
TABLE 126 GCC Countries Venous Stents Market, by Disease, 2023-2030 (US$ Bn)
TABLE 127 South Africa Venous Stents Market, by Application, 2017-2022 (US$ Bn)
TABLE 128 South Africa Venous Stents Market, by Application, 2023-2030 (US$ Bn)
TABLE 129 South Africa Venous Stents Market, by Disease, 2017-2022 (US$ Bn)
TABLE 130 South Africa Venous Stents Market, by Disease, 2023-2030 (US$ Bn)
TABLE 131 Rest of Middle East and Africa Venous Stents Market, by Application, 2017-2022 (US$ Bn)
TABLE 132 Rest of Middle East and Africa Venous Stents Market, by Application, 2023-2030 (US$ Bn)
TABLE 133 Rest of Middle East and Africa Venous Stents Market, by Disease, 2017-2022 (US$ Bn)
TABLE 134 Rest of Middle East and Africa Venous Stents Market, by Disease, 2023-2030 (US$ Bn)

Frequently Asked Questions

What is the current size of the global venous stents market?

The global venous stents market was valued at USD 0.87 Billion in 2022.

What is the expected growth rate of the venous stents market between 2023 and 2030?

The venous stents market is expected to grow at a CAGR of 8.50% between 2023 and 2030, reaching USD 1.54 Billion in 2030.

Which segment is leading the market share in terms of application?

Leg is the leading segment by material, holding over 43% share in terms of value in 2022.

Which disease segment governs the demand for venous stents in the world?

The chronic deep vein thrombosis segment governs the demand for venous stents globally, holding a massive share of over 80% in 2022.

Which region is fueling the growth of the venous stents industry?

North America is fueling the growth of the venous stents industry, with an over one-third share in 2022.

Who are the major players in the global venous stents market?

The top players include Boston Scientific Corporation, Becton, Dickinson and Company, Gore Medical, Cook Medical, Optimed Medizinische Instrumente GmBH, Medtronic Plc, Medica Germany GMBH & Co. KG, Cordis Inc., and MicroPort Scientific Corporation

What are the major market drivers of the venous stents industry?

Investments made by major companies in the development of flexible venous stents with high radial strength and rising healthcare spending are the major market drivers.

What are the major market restraints of the venous stents industry?

The major market restraints include a lack of awareness of venous stents and the high cost of stenting.

What are the major market opportunities of the venous stents industry?

The huge growth potential in Asia Pacific, increasing adoption from educational institutes, and new ways of distribution are the major opportunities in the venous stents industry.

Physical Therapy Supplies Market

Published:
Report ID: 43078

Multiplex Biomarker Imaging Market

Published:
Report ID: 43073

Remote Patient Monitoring Devices Market

Published:
Report ID: 20624

Human Platelet lysate Market

Published:
Report ID: 43016

Orthopedic Power Tools Market

Published:
Report ID: 42912

C Arms Devices Market

Published:
Report ID: 42645

Dental Implants and Prosthetics Market

Published:
Report ID: 42604

Surgical Tourniquets Market

Published:
Report ID: 42535

Vascular Access Systems Market

Published:
Report ID: 42543

Trigeminal Neuralgia Treatment Market

Published:
Report ID: 11788

Dermal Fillers and Botulinum Toxin Market

Published:
Report ID: 42459

Transcatheter Mitral Valve Market

Published:
Report ID: 42392

Purchase Options

$2999
Delivery Format: Excel.
$4999
Designed for the individual purchaser.
$6999
Users located at a single corporate site or regional office.
$7999
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN